News
Eric Green, M.D., Ph.D., formerly the NHGRI director, has been awarded by Fierce Pharma as a Fierce 50 Innovation Honoree. The Fierce 50 is designed to honor the 50 most influential leaders and organizations shaping the future of biopharma, healthcare, and life sciences. The Fierce editorial team
Register to attend a free NIH webinar featuring a licensing opportunity for a first-of-its-kind male contraceptive hormonal gel, Nestorone®/Testosterone (NES/T), co-developed by the NICHD and Population Council through the Contraceptive Clinical Trials Network (CCTN). This topical, daily self
The National Institutes of Health (NIH) engaged RTI International, a nonprofit research institute, to develop new methods for characterizing and measuring the impact of technologies developed by NIH’s Intramural Research Program. The RTI team created models to illustrate how technologies licensed
Are you interested in achieving commercial success with NIH as a strategic partner? Michael Salgaller of the National Cancer Institute (NCI) is leading a workshop at the MedInvest Oncology Investor Conference on how to partner with NIH to bring one of over 2,000 available inventions to market. This